The ADIPO-CARE Plan: A Comprehensive Implementation Framework for the Diagnosis and Management of People Living with Obesity—Experts’ Proposal
Authors:
- Stanisław SurmaSSStanisław Surma
- Marcin BarylskiMBMarcin Barylski
- Deepak L. BhattDBDeepak L. Bhatt
- Kausik K. RayKRKausik K. Ray
- Michael D. ShapiroMSMichael D. Shapiro
- Giuseppe ManciaGiuseppe Mancia
- Gregory Y. H. LipGregory Y. H. Lip
- Claudio BorghiClaudio Borghi
- Roland E. SchmiederRSRoland E. Schmieder
- Krzysztof NarkiewiczKNKrzysztof Narkiewicz
- Alina KuryłowiczAKAlina Kuryłowicz
Open Access
Abstract
Obesity is a chronic, recurrent, and heterogeneous disease whose effective treatment requires an approach that goes beyond assessment of body mass index and short-term weight loss. Contemporary management should integrate assessment of adipose tissue distribution and function, obesity phenotype, complications, and cardiometabolic risk with individualized nutritional, behavioral, pharmacological, and—if appropriate—surgical interventions. This paper presents the ADIPO–CARE Plan, a practical, structured model for the comprehensive assessment and long-term treatment of people living with obesity. The model comprises two interconnected stages. The ADIPO defines a comprehensive clinical assessment process: A—Assess adiposity, which includes assessing the degree and distribution of excess adipose tissue; D—Define obesity phenotype, which aims to identify the clinical phenotype of obesity; I—Identify complications, which includes detecting obesity-related diseases and complications; P—Profile cardiometabolic risk, which serves to determine global cardiometabolic risk and disease severity; and O—Overall treatment goals, defining individual, realistic therapeutic goals that go beyond weight loss. The second phase, CARE, organizes the treatment and long-term follow-up strategy: C—Comprehensive lifestyle intervention, with particular emphasis on nutritional therapy, physical activity, behavioral interventions, and lifestyle modifications; A—Anti-obesity pharmacotherapy, encompassing the rational use of pharmacotherapy as a complement to lifestyle interventions; R—Response-guided treatment optimization, involving systematic assessment of response and intensification or modification of therapy; and E—Evaluate long-term effectiveness, focusing on maintenance of effects, safety, adherence, relapse prevention, and long-term disease control. The ADIPO–CARE Plan proposes a shift from an approach focused primarily on body weight to a model focused on phenotype, risks, complications, and long-term health benefits. This framework can facilitate the systematization of clinical decisions and the integration of nutritional therapy with other elements of modern, personalized obesity therapy.Keywords
This publication has 120 references indexed in Scilit:
- Heart Failure and Obesity: Translational Approaches and Therapeutic Perspectives. A Scientific Statement of the Heart Failure Association of the ESCEuropean Journal of Heart Failure, 2025
- An Energy-Reduced Mediterranean Diet, Physical Activity, and Body CompositionJAMA Network Open, 2023
- Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary DiseasesJAMA Internal Medicine, 2022
- Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity ClinicObesity, 2021
- Effect of Obesogenic Medication on Weight‐ and Fitness‐Change Outcomes: Evidence from the Look AHEAD StudyObesity, 2020
- Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in AdultsJAMA, 2018
- Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss in Overweight Adults and the Association With Genotype Pattern or Insulin SecretionJAMA, 2018
- Comparative effectiveness of three doses of weight-loss counseling: Two-year findings from the rural LITE trialObesity, 2014
- Bariatric Surgery and Long-term Cardiovascular EventsJAMA, 2012
- Overweight, Obesity, and DepressionArchives of General Psychiatry, 2010